Showing 1251-1260 of 7029 results for "".
Pearls from NYC: Oy Vey!
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pearls-from-nyc-oy-vey-/18752/By Gary Goldenberg, MD and Seemal R. Desai, MDWhat happens if you shave a melanoma? Dr. Goldenberg addresses a common question from the clinic. The good news? The type of biopsy done does not appear to affect long-term survival in melanoma.New Thinking: Eczema as a Systemic Disease
https://practicaldermatology.com/topics/psoriasis/new-thinking-eczema-as-a-systemic-disease/18756/By Seemal R. Desai, MD and Emma Guttman, MD, PhD, FAADEczema is an immune-driven disease like psoriasis. How is that knowledge changing the way that dermatologists treat patients? Are similar changes taking place for other inflammatory diseases? Dr. Guttman talks about the latest.Getting the Upper Hand on NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/getting-the-upper-hand-on-nmsc/18758/By Seemal R. Desai, MD and Anthony Rossi, MDDecide what type of treatment to use to treat the specific, biopsy-confirmed presentation, says Dr. Rossi. He shares tips to optimize topical treatment outcomes in non-melanoma skin cancer.Patient Education: The Heart of Your Plan
https://practicaldermatology.com/topics/practice-management/patient-education-the-heart-of-your-plan/20928/Your office must be equipped with proper strategies to engage and educate if you want to make a lasting impression with your patients.Vegas Cosmetic Surgery 2016 Update
https://practicaldermatology.com/topics/practice-management/vegas-cosmetic-surgery-2016-update/18764/Highlights from the Vegas Cosmetic Surgery 2016 meeting at the Bellagio hotel. Get insights from speakers: Timothy Miller, MD, Jason Bloom, MD, Jeffrey Spiegel, MD, David Evans, Mara Shorr, BS, CAC II-VII, Donn Chatham, MD, Wendy Lee, MD, Jay Shorr, BA, MBM-C, CAC I-VIII. Topics include neurotoxins,Where is Dermatology Headed?
https://practicaldermatology.com/topics/psoriasis/where-is-dermatology-headed/18590/Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the future of dermatology in this episode of Derm Insider. They talk about how an increased focus on research in the last few years is leading to new treatments and new understanding aboutA Branded World
https://practicaldermatology.com/topics/practice-management/a-branded-world/20968/A logo is just one of many critical steps to building a brand that patients connect with. Here's what you need to know.To Be Shorr: Your receptionist is director of first impressions
https://practicaldermatology.com/topics/practice-management/to-be-shorr-your-receptionist-is-director-of-first-impressions/18603/Th best physicians and surgeons can see their practice fall apart if they lack good staff. The receptionist is often the first contact a patient has with your practice. Think of this individual as your director of first impressions, says Mara Shorr, BS, CAC II-V.New Treatment Algorithms for Actinic Keratoses
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-treatment-algorithms-for-actinic-keratoses/18812/Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it's important to treat the field and not just the visible lesions. He shares his evidence-based, time-sequential therapy approach to combining a destructive modality with field therapy to pLong-Term Effects of Neuromodulators on Aging
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/long-term-effects-of-neuromodulators-on-aging/18810/Shannon Humphrey, MD discusses the cumulative anti-aging benefits of long-term treatments with botulinum toxin type A. She shares her observations from the bench and offers a review of what the literature shows to support her recommendation for regular conservative neuromodulator treatments to impro